nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.737	1	CbGbCtD
Clofarabine—RRM1—Synthesis and interconversion of nucleotide di- and triphosphates—GSR—amyotrophic lateral sclerosis	0.0072	0.118	CbGpPWpGaD
Clofarabine—Pericarditis—Riluzole—amyotrophic lateral sclerosis	0.00691	0.038	CcSEcCtD
Clofarabine—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.00638	0.035	CcSEcCtD
Clofarabine—RRM1—E2F transcription factor network—UXT—amyotrophic lateral sclerosis	0.00613	0.1	CbGpPWpGaD
Clofarabine—RRM2—Synthesis and interconversion of nucleotide di- and triphosphates—GSR—amyotrophic lateral sclerosis	0.00593	0.0971	CbGpPWpGaD
Clofarabine—Lymphopenia—Riluzole—amyotrophic lateral sclerosis	0.00584	0.0321	CcSEcCtD
Clofarabine—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.00527	0.0289	CcSEcCtD
Clofarabine—RRM2—E2F transcription factor network—UXT—amyotrophic lateral sclerosis	0.00505	0.0827	CbGpPWpGaD
Clofarabine—Polyp—Riluzole—amyotrophic lateral sclerosis	0.00491	0.027	CcSEcCtD
Clofarabine—Respiratory distress—Riluzole—amyotrophic lateral sclerosis	0.00471	0.0258	CcSEcCtD
Clofarabine—Oral candidiasis—Riluzole—amyotrophic lateral sclerosis	0.00471	0.0258	CcSEcCtD
Clofarabine—Cyst—Riluzole—amyotrophic lateral sclerosis	0.00447	0.0246	CcSEcCtD
Clofarabine—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.0043	0.0236	CcSEcCtD
Clofarabine—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.0039	0.0214	CcSEcCtD
Clofarabine—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00363	0.02	CcSEcCtD
Clofarabine—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.00355	0.0195	CcSEcCtD
Clofarabine—POLA1—E2F transcription factor network—UXT—amyotrophic lateral sclerosis	0.00345	0.0566	CbGpPWpGaD
Clofarabine—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00331	0.0182	CcSEcCtD
Clofarabine—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00329	0.0181	CcSEcCtD
Clofarabine—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.00316	0.0174	CcSEcCtD
Clofarabine—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00304	0.0167	CcSEcCtD
Clofarabine—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00299	0.0164	CcSEcCtD
Clofarabine—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00285	0.0157	CcSEcCtD
Clofarabine—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.0027	0.0148	CcSEcCtD
Clofarabine—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00266	0.0146	CcSEcCtD
Clofarabine—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00259	0.0142	CcSEcCtD
Clofarabine—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00243	0.0133	CcSEcCtD
Clofarabine—RRM1—Nucleotide metabolism—GSR—amyotrophic lateral sclerosis	0.00223	0.0365	CbGpPWpGaD
Clofarabine—RRM2—embryo—amyotrophic lateral sclerosis	0.00221	0.112	CbGeAlD
Clofarabine—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00217	0.0119	CcSEcCtD
Clofarabine—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00202	0.0111	CcSEcCtD
Clofarabine—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00195	0.0107	CcSEcCtD
Clofarabine—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00191	0.0105	CcSEcCtD
Clofarabine—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00188	0.0103	CcSEcCtD
Clofarabine—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00184	0.0101	CcSEcCtD
Clofarabine—RRM2—Nucleotide metabolism—GSR—amyotrophic lateral sclerosis	0.00183	0.0301	CbGpPWpGaD
Clofarabine—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00978	CcSEcCtD
Clofarabine—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00963	CcSEcCtD
Clofarabine—DCK—Nucleotide metabolism—GSR—amyotrophic lateral sclerosis	0.00171	0.0281	CbGpPWpGaD
Clofarabine—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00932	CcSEcCtD
Clofarabine—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00924	CcSEcCtD
Clofarabine—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00918	CcSEcCtD
Clofarabine—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00918	CcSEcCtD
Clofarabine—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00164	0.009	CcSEcCtD
Clofarabine—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00895	CcSEcCtD
Clofarabine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00895	CcSEcCtD
Clofarabine—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00876	CcSEcCtD
Clofarabine—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00869	CcSEcCtD
Clofarabine—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00866	CcSEcCtD
Clofarabine—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00862	CcSEcCtD
Clofarabine—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00829	CcSEcCtD
Clofarabine—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00824	CcSEcCtD
Clofarabine—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00814	CcSEcCtD
Clofarabine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00812	CcSEcCtD
Clofarabine—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00148	0.0081	CcSEcCtD
Clofarabine—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00808	CcSEcCtD
Clofarabine—DCK—embryo—amyotrophic lateral sclerosis	0.00143	0.0723	CbGeAlD
Clofarabine—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00779	CcSEcCtD
Clofarabine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00765	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00139	0.0227	CbGpPWpGaD
Clofarabine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00748	CcSEcCtD
Clofarabine—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00745	CcSEcCtD
Clofarabine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00743	CcSEcCtD
Clofarabine—Chills—Riluzole—amyotrophic lateral sclerosis	0.00135	0.0074	CcSEcCtD
Clofarabine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00728	CcSEcCtD
Clofarabine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00722	CcSEcCtD
Clofarabine—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00718	CcSEcCtD
Clofarabine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00694	CcSEcCtD
Clofarabine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00672	CcSEcCtD
Clofarabine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00663	CcSEcCtD
Clofarabine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00659	CcSEcCtD
Clofarabine—RRM1—medulla oblongata—amyotrophic lateral sclerosis	0.00117	0.0595	CbGeAlD
Clofarabine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00642	CcSEcCtD
Clofarabine—Cough—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00626	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00113	0.0185	CbGpPWpGaD
Clofarabine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00113	0.0062	CcSEcCtD
Clofarabine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00611	CcSEcCtD
Clofarabine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00611	CcSEcCtD
Clofarabine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00609	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00607	CcSEcCtD
Clofarabine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00586	CcSEcCtD
Clofarabine—RRM2—nervous system—amyotrophic lateral sclerosis	0.00106	0.0538	CbGeAlD
Clofarabine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00582	CcSEcCtD
Clofarabine—RRM1—spinal cord—amyotrophic lateral sclerosis	0.00105	0.053	CbGeAlD
Clofarabine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00574	CcSEcCtD
Clofarabine—POLA1—cerebellum—amyotrophic lateral sclerosis	0.00105	0.053	CbGeAlD
Clofarabine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00573	CcSEcCtD
Clofarabine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00572	CcSEcCtD
Clofarabine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00569	CcSEcCtD
Clofarabine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00566	CcSEcCtD
Clofarabine—RRM2—central nervous system—amyotrophic lateral sclerosis	0.00102	0.0518	CbGeAlD
Clofarabine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00558	CcSEcCtD
Clofarabine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000997	0.00547	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000972	0.00534	CcSEcCtD
Clofarabine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000958	0.00526	CcSEcCtD
Clofarabine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000951	0.00522	CcSEcCtD
Clofarabine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000948	0.00521	CcSEcCtD
Clofarabine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000927	0.00509	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000921	0.00506	CcSEcCtD
Clofarabine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00092	0.00505	CcSEcCtD
Clofarabine—Pain—Riluzole—amyotrophic lateral sclerosis	0.000912	0.00501	CcSEcCtD
Clofarabine—DCK—medulla oblongata—amyotrophic lateral sclerosis	0.000912	0.0462	CbGeAlD
Clofarabine—RRM1—nervous system—amyotrophic lateral sclerosis	0.000882	0.0447	CbGeAlD
Clofarabine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000879	0.00483	CcSEcCtD
Clofarabine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000872	0.00479	CcSEcCtD
Clofarabine—POLA1—brain—amyotrophic lateral sclerosis	0.000849	0.043	CbGeAlD
Clofarabine—RRM1—central nervous system—amyotrophic lateral sclerosis	0.000849	0.043	CbGeAlD
Clofarabine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000843	0.00463	CcSEcCtD
Clofarabine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000843	0.00463	CcSEcCtD
Clofarabine—RRM1—cerebellum—amyotrophic lateral sclerosis	0.00083	0.0421	CbGeAlD
Clofarabine—DCK—spinal cord—amyotrophic lateral sclerosis	0.000813	0.0412	CbGeAlD
Clofarabine—RRM2—brain—amyotrophic lateral sclerosis	0.000812	0.0411	CbGeAlD
Clofarabine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000786	0.00432	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000781	0.0128	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000777	0.0127	CbGpPWpGaD
Clofarabine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000765	0.0042	CcSEcCtD
Clofarabine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000755	0.00414	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000754	0.0124	CbGpPWpGaD
Clofarabine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00073	0.00401	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00071	0.0116	CbGpPWpGaD
Clofarabine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000705	0.00387	CcSEcCtD
Clofarabine—DCK—nervous system—amyotrophic lateral sclerosis	0.000685	0.0347	CbGeAlD
Clofarabine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000678	0.00372	CcSEcCtD
Clofarabine—RRM1—brain—amyotrophic lateral sclerosis	0.000674	0.0342	CbGeAlD
Clofarabine—Rash—Riluzole—amyotrophic lateral sclerosis	0.000672	0.00369	CcSEcCtD
Clofarabine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000672	0.00369	CcSEcCtD
Clofarabine—Headache—Riluzole—amyotrophic lateral sclerosis	0.000668	0.00367	CcSEcCtD
Clofarabine—DCK—central nervous system—amyotrophic lateral sclerosis	0.00066	0.0334	CbGeAlD
Clofarabine—DCK—cerebellum—amyotrophic lateral sclerosis	0.000645	0.0327	CbGeAlD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000636	0.0104	CbGpPWpGaD
Clofarabine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000634	0.00348	CcSEcCtD
Clofarabine—RRM1—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000603	0.00988	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000548	0.00898	CbGpPWpGaD
Clofarabine—DCK—brain—amyotrophic lateral sclerosis	0.000524	0.0265	CbGeAlD
Clofarabine—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000509	0.0258	CbGeAlD
Clofarabine—RRM2—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000497	0.00814	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000462	0.00757	CbGpPWpGaD
Clofarabine—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.000454	0.023	CbGeAlD
Clofarabine—RRM2—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.00045	0.00738	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.00045	0.00738	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000441	0.00723	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000438	0.00717	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000425	0.00696	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.000403	0.0066	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.000403	0.0066	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.0004	0.00656	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.0004	0.00656	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.0004	0.00655	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.000383	0.00628	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000366	0.006	CbGpPWpGaD
Clofarabine—ABCG2—cerebellum—amyotrophic lateral sclerosis	0.00036	0.0182	CbGeAlD
Clofarabine—RRM2—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000343	0.00561	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00034	0.00557	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000329	0.0054	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000329	0.0054	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00032	0.00524	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000309	0.00506	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.000308	0.00505	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.000308	0.00505	CbGpPWpGaD
Clofarabine—DCK—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000308	0.00505	CbGpPWpGaD
Clofarabine—DCK—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000308	0.00505	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000301	0.00494	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.0003	0.00492	CbGpPWpGaD
Clofarabine—ABCG2—brain—amyotrophic lateral sclerosis	0.000292	0.0148	CbGeAlD
Clofarabine—RRM1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000289	0.00474	CbGpPWpGaD
Clofarabine—DCK—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000282	0.00461	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00028	0.00459	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.000278	0.00455	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.000276	0.00452	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.000276	0.00452	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000263	0.00432	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.000262	0.00429	CbGpPWpGaD
Clofarabine—DCK—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000262	0.00429	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.00026	0.00427	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000249	0.00408	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000248	0.00407	CbGpPWpGaD
Clofarabine—DCK—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000246	0.00403	CbGpPWpGaD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.00024	0.00393	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000238	0.0039	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000234	0.00384	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000231	0.00378	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.000229	0.00375	CbGpPWpGaD
Clofarabine—DCK—Metabolism—DAO—amyotrophic lateral sclerosis	0.000223	0.00365	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000219	0.00359	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.000214	0.0035	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000202	0.00332	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000199	0.00327	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000196	0.00321	CbGpPWpGaD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000186	0.00304	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000181	0.00296	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000169	0.00277	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000169	0.00276	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000167	0.00273	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000166	0.00272	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.000156	0.00256	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSR—amyotrophic lateral sclerosis	0.000156	0.00255	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000148	0.00243	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000141	0.00231	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.00014	0.0023	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000137	0.00224	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.00013	0.00213	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000128	0.00211	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000128	0.0021	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000123	0.00202	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000123	0.00202	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000113	0.00185	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.00011	0.00181	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000109	0.00179	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000109	0.00179	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000105	0.00172	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	9.85e-05	0.00161	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	9.74e-05	0.0016	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.93e-05	0.00146	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	8.91e-05	0.00146	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	8.34e-05	0.00137	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.2e-05	0.00134	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.35e-05	0.0012	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.87e-05	0.00113	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.76e-05	0.00111	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—APOE—amyotrophic lateral sclerosis	6.75e-05	0.00111	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	6.75e-05	0.00111	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.31e-05	0.00103	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	6.23e-05	0.00102	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—APOE—amyotrophic lateral sclerosis	5.56e-05	0.000911	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TP53—amyotrophic lateral sclerosis	5.28e-05	0.000865	CbGpPWpGaD
Clofarabine—DCK—Metabolism—APOE—amyotrophic lateral sclerosis	5.19e-05	0.000851	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	5.12e-05	0.000838	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.63e-05	0.000758	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.81e-05	0.000624	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TP53—amyotrophic lateral sclerosis	3.61e-05	0.000592	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.56e-05	0.000583	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.75e-05	0.000451	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.53e-05	0.000414	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	2.08e-05	0.000341	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.42e-05	0.000233	CbGpPWpGaD
